Why Stem Cells Could Replace Expensive Pet Meds: Dr. Linda Black in The Woof

In a recent interview with The Woof, Gallant CEO Dr. Linda Black, DVM, PhD, sat down to discuss the promise of regenerative medicine and how stem cells may one day reduce reliance on expensive, long-term medications for pets.

The conversation highlighted the limitations of current therapies, which often focus on managing symptoms rather than addressing the root cause of disease. Dr. Black explained how ready-to-use stem cell therapies—currently under investigation—could transform care for chronic conditions in dogs and cats by restoring health at the source rather than masking illness.

“Gallant is not just about helping pets feel better,” Dr. Black shared. “It’s about giving them the chance to truly get better.”

The interview also underscored Gallant’s mission to make science-backed, FDA-regulated therapies accessible to everyday veterinary practices. By reducing dependence on steroids and other chronic medications, regenerative approaches may help veterinarians provide care that is both more effective and easier for pet parents to manage.

From The Woof
Why Stem Cells Could Replace Expensive Pet Meds